Ascendis Health (JSE:ASC) Cash, Cash Equivalents, Marketable Securities : R104 Mil (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Cash, Cash Equivalents, Marketable Securities?

Ascendis Health's quarterly cash, cash equivalents, marketable securities declined from Jun. 2022 (R264.04 Mil) to Dec. 2022 (R125.06 Mil) but then stayed the same from Dec. 2022 (R125.06 Mil) to Jun. 2023 (R104.08 Mil).

Ascendis Health's annual cash, cash equivalents, marketable securities declined from Jun. 2021 (R365.99 Mil) to Jun. 2022 (R264.04 Mil) and declined from Jun. 2022 (R264.04 Mil) to Jun. 2023 (R104.08 Mil).

Ascendis Health Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Ascendis Health's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Cash, Cash Equivalents, Marketable Securities Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

470.55

398.19

365.99

264.04

104.08

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															365.99	291.61	264.04	125.06	104.08

Ascendis Health Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ascendis Health (JSE:ASC) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Ascendis Health Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.